EMA: APPLICATION IS FOR TREATMENT OF MILD-TO-MODERATE COVID 19 IN ADULT AND ADOLESCENT PATIENTS WHO ARE AT HIGH RISK OF PROGRESSION TO SEVERE COVID 19